ASCO Guidelines

Updated ASCO Guidelines strongly recommend use of the Oncotype DX Breast Recurrence Score® Test in node-negative and the majority of node-positive early-stage breast cancer patients

AUA 2022

May 12-16th, 2022 in New Orleans, LA

Visit us at booth 647 for exclusive access to the 2022 Guidelines at a Glance Prostate Cancer Edition.
Making cancer care smarter.™